MyAV·¶H proton beam therapy centre treats first patients
4 February 2022
A new national proton beam therapy centre based at MyAV·¶H treated its first patients in December 2021.
Treatment plans (craniospinal and ewing sarcoma) highlighting an x-ray vs proton comparison
One of only twoÌýNHSÌýproton beam centres in the UK, the new centre at MyAV·¶H brings together some of the world’s leading specialists in complex cancers and will drive forward research into what remains a relatively new treatment.
The advantage of proton beam therapy over conventional radiotherapy is that the bulk of the energy is delivered directly to the tumour with no exit dose. This limits the impact on the surrounding healthy tissue, leading to fewer side-effects and reduced long term consequences, including the risk of a secondary malignancy. Patients treated with PBT range from very young children to adults who have hard to treat cancers. These may be tumours in the brain, on the spine, or near the reproductive organs, where it is particularly important to protect the surrounding tissue. Around a third of the patients will be children and teenagers.Ìý
MyAV·¶ Medical Physics and Biomedical Engineering researchers and Ìýand their teamÌýare working in partnership with MyAV·¶H to advance the future of cancer therapy through their research on proton beam therapyÌýand in the development of clinical trials.Ìý
Find out more on and about theÌý.
MyAV·¶ Medical Physics and Biomedical Engineering, in partnership with MyAV·¶H and IPEM will be holding a public lecture on Proton Therapy in Spring 2022, details to follow.Ìý
Ìý